Ensartinib - Betta Pharmaceuticals/Xcovery
At a glance
- Drug Originator Xcovery
- Drug Licenced by Betta Pharmaceuticals Co Ltd; Zhejiang Betta Pharma
- Drug Class Antineoplastics; Piperazines; Pyridazines; Small molecules
- Mechanism of Action Anaplastic lymphoma kinase inhibitors; EphA2 receptor antagonists; Proto-oncogene protein c-met inhibitors; ROS1 protein inhibitors; TrkA receptor antagonists; TrkC receptor antagonists
- USA Patent Applicants XCOVERY
- USA Patents 5
- NDAs 1
- International Patents 67

Disclaimer